Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3028% below fair value
$3.31+0.24 (+7.82%)
Close on Nov 12, 2026Market cap $35.95MP/E 18.4Yield –
Nephros profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Nephros's profit margin for the twelve months ending Sep 30, 2026 was 8.9%. For fiscal 2025 it was 6.4%, against 0.5% the year before. The highest annual figure on record is 132.1% in fiscal 2010.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.4% | +5.8 |
| FY2024 | Dec 31, 2024 | 0.5% | +11.6 |
| FY2023 | Dec 31, 2023 | -11.1% | +26.8 |
| FY2021 | Dec 31, 2021 | -37.8% | +15.0 |
| FY2020 | Dec 31, 2020 | -52.9% | −22.1 |
| FY2019 | Dec 31, 2019 | -30.8% | +29.1 |
| FY2018 | Dec 31, 2018 | -59.8% | −38.6 |
| FY2017 | Dec 31, 2017 | -21.2% | +109.5 |
| FY2016 | Dec 31, 2016 | -130.7% | +28.2 |
| FY2015 | Dec 31, 2015 | -158.8% | +262.8 |
| FY2014 | Dec 31, 2014 | -421.7% | −497.7 |
| FY2013 | Dec 31, 2013 | 76.0% | +442.5 |
| FY2012 | Dec 31, 2012 | -366.5% | −50.4 |
| FY2011 | Dec 31, 2011 | -316.1% | −448.1 |
| FY2010 | Dec 31, 2010 | 132.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 9.1% | +2.0 |
| Q2 FY2026 | Jun 30, 2026 | 19.9% | +14.5 |
| Q1 FY2026 | Mar 31, 2026 | 2.7% | −8.8 |
| Q4 FY2025 | Dec 31, 2025 | 1.3% | −7.7 |
| Q3 FY2025 | Sep 30, 2025 | 7.1% | +1.9 |
| Q2 FY2025 | Jun 30, 2025 | 5.4% | +14.3 |
| Q1 FY2025 | Mar 31, 2025 | 11.4% | +16.2 |
| Q4 FY2024 | Dec 31, 2024 | 9.0% | +29.1 |
| Q3 FY2024 | Sep 30, 2024 | 5.2% | +10.1 |
| Q2 FY2024 | Jun 30, 2024 | -8.9% | +3.3 |
| Q1 FY2024 | Mar 31, 2024 | -4.8% | +3.5 |
| Q4 FY2023 | Dec 31, 2023 | -20.1% | +114.0 |
| Q3 FY2023 | Sep 30, 2023 | -4.9% | +35.0 |
| Q2 FY2023 | Jun 30, 2023 | -12.2% | +78.9 |
| Q1 FY2023 | Mar 31, 2023 | -8.3% | +23.5 |
| Q3 FY2022 | Sep 30, 2022 | -134.1% | −86.7 |
| Q2 FY2022 | Jun 30, 2022 | -39.9% | +9.8 |
| Q1 FY2022 | Mar 31, 2022 | -91.1% | −71.5 |
| Q4 FY2021 | Dec 31, 2021 | -31.8% | +0.7 |
| Q3 FY2021 | Sep 30, 2021 | -47.4% | +0.3 |
| Q2 FY2021 | Jun 30, 2021 | -49.7% | +55.4 |
| Q1 FY2021 | Mar 31, 2021 | -19.6% | +23.8 |
| Q4 FY2020 | Dec 31, 2020 | -32.5% | −28.0 |
| Q3 FY2020 | Sep 30, 2020 | -47.7% | −23.7 |
| Q2 FY2020 | Jun 30, 2020 | -105.1% | −64.3 |
| Q1 FY2020 | Mar 31, 2020 | -43.4% | +32.8 |
| Q4 FY2019 | Dec 31, 2019 | -4.6% | +40.4 |
| Q3 FY2019 | Sep 30, 2019 | -24.0% | +8.8 |
| Q2 FY2019 | Jun 30, 2019 | -40.8% | +9.1 |
| Q1 FY2019 | Mar 31, 2019 | -76.3% | +68.8 |
| Q4 FY2018 | Dec 31, 2018 | -45.0% | −144.1 |
| Q3 FY2018 | Sep 30, 2018 | -32.8% | +36.2 |
| Q2 FY2018 | Jun 30, 2018 | -49.9% | +41.6 |
| Q1 FY2018 | Mar 31, 2018 | -145.1% | −52.4 |
| Q4 FY2017 | Dec 31, 2017 | 99.2% | +187.1 |
| Q3 FY2017 | Sep 30, 2017 | -69.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -91.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -92.6% | – |
| Q4 FY2016 | Dec 31, 2016 | -87.9% | – |
See a number that looks wrong?